FI810027L - Hybridcellinje foer framstaellning av en monoklonal antikropp mot en maensklig monosytantigen den saolunda framstaellda antikroppen samt foerfaranden i vilka antikroppen anvaends - Google Patents

Hybridcellinje foer framstaellning av en monoklonal antikropp mot en maensklig monosytantigen den saolunda framstaellda antikroppen samt foerfaranden i vilka antikroppen anvaends

Info

Publication number
FI810027L
FI810027L FI810027A FI810027A FI810027L FI 810027 L FI810027 L FI 810027L FI 810027 A FI810027 A FI 810027A FI 810027 A FI810027 A FI 810027A FI 810027 L FI810027 L FI 810027L
Authority
FI
Finland
Prior art keywords
monoclonal
monocytantigen
antikroppen
anticrope
antikropp
Prior art date
Application number
FI810027A
Other languages
English (en)
Other versions
FI75600B (fi
FI75600C (fi
Inventor
Patrick Chung-Shu Kung
Gideon Goldstein
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22333400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI810027(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of FI810027L publication Critical patent/FI810027L/fi
Priority to FI850485A priority Critical patent/FI75233C/fi
Publication of FI75600B publication Critical patent/FI75600B/fi
Application granted granted Critical
Publication of FI75600C publication Critical patent/FI75600C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Microwave Amplifiers (AREA)
  • Liquid Developers In Electrophotography (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
FI810027A 1980-01-08 1981-01-07 Foerfarande foer framstaellning av en monoklonal antikropp mot en maensklig monocytantigen medelst en ny hybridcellinje. FI75600C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI850485A FI75233C (fi) 1980-01-08 1985-02-06 Diagnostiskt foerfarande, vid vilket man utnyttjar en ny monoklonal antikropp specifik mot maenniskans monocytantigen och i foerfarandet anvaendbar komposition.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11050980 1980-01-08
US06/110,509 US4364936A (en) 1980-01-08 1980-01-08 Monoclonal antibody to a human monocyte antigen and methods of preparing same

Publications (3)

Publication Number Publication Date
FI810027L true FI810027L (fi) 1981-07-09
FI75600B FI75600B (fi) 1988-03-31
FI75600C FI75600C (fi) 1988-07-11

Family

ID=22333400

Family Applications (1)

Application Number Title Priority Date Filing Date
FI810027A FI75600C (fi) 1980-01-08 1981-01-07 Foerfarande foer framstaellning av en monoklonal antikropp mot en maensklig monocytantigen medelst en ny hybridcellinje.

Country Status (21)

Country Link
US (1) US4364936A (fi)
EP (1) EP0033579B1 (fi)
JP (2) JPS56103116A (fi)
AT (1) ATE14899T1 (fi)
AU (1) AU545185B2 (fi)
CA (1) CA1175368A (fi)
DE (2) DE3171753D1 (fi)
DK (1) DK154093C (fi)
ES (1) ES8303917A1 (fi)
FI (1) FI75600C (fi)
GR (1) GR72412B (fi)
HK (1) HK24586A (fi)
IE (1) IE50802B1 (fi)
IL (1) IL61863A (fi)
MY (1) MY8700059A (fi)
NO (1) NO159622C (fi)
NZ (1) NZ195944A (fi)
PT (1) PT72319B (fi)
SG (1) SG7186G (fi)
YU (1) YU44321B (fi)
ZA (1) ZA8198B (fi)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4912045A (en) * 1980-01-08 1990-03-27 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human monocyte, antigen, antibody and methods
US4959458A (en) * 1980-01-08 1990-09-25 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human monocyte antigen, antibody, and methods
US5196310A (en) * 1980-01-08 1993-03-23 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human monocyte antigen, antibody, and methods
US4582797A (en) * 1980-09-25 1986-04-15 The Salk Institute For Biological Studies Monoclonal antibodies specific for human hematopoietic cell surface glycoproteins
US4434156A (en) 1981-10-26 1984-02-28 The Salk Institute For Biological Studies Monoclonal antibodies specific for the human transferrin receptor glycoprotein
USRE32011E (en) * 1981-12-14 1985-10-22 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
EP0096839B1 (en) * 1982-06-09 1989-01-25 Asahi Kasei Kogyo Kabushiki Kaisha Method for producing human antibody
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
EP0117705A3 (en) * 1983-02-24 1985-09-25 The Regents Of The University Of California Monoclonal antibody specific for monocytes and blast cells
US4579827A (en) * 1983-03-11 1986-04-01 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies to human gastrointestinal cancers and hybridoma method of production of the monoclonal antibodies
FI841281A (fi) * 1983-03-31 1984-10-01 Scripps Clinic Res Ny faktor foer viii koagulenta polypeptider och deras monoklonala antikroppar.
US5362854A (en) * 1983-03-31 1994-11-08 Scripps Clinic & Research Foundation Factor VIII coagulant polypeptides: method of making
US4468346A (en) * 1983-10-27 1984-08-28 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to porcine immunoglobulins
JPS60231699A (ja) * 1983-11-09 1985-11-18 Aichiken 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体
US4772552A (en) * 1984-04-23 1988-09-20 Dana-Farber Cancer Institute, Inc. Monoclonal antibody which recognizes a 200-220 KD antigen on natural killer cells
US4599305A (en) * 1984-07-16 1986-07-08 The Regents Of The University Of California Method and composition for detection of human chronic myelogenous leukemia
US4562003A (en) * 1984-10-26 1985-12-31 California Biotechnology, Inc. Monoclonal antibodies against alveolar surfactant protein
US5431897A (en) * 1985-04-19 1995-07-11 Sloan-Kettering Institute For Cancer Research Method of imaging colorectal carcinoma lesion and composition for use therein
AU6032786A (en) * 1985-07-25 1987-01-29 University Of Minnesota Detection, imaging and therapy of renal cell carcinoma with monoclonal antibodies in vivo
US4970299A (en) * 1986-07-03 1990-11-13 Sloan-Kettering Institute For Cancer Research Monoclonal antibodies selective for prostate cancer
US5601819A (en) * 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
AU1539699A (en) * 1997-11-24 1999-06-15 Johnson T. Wong Methods for treatment of hiv or other infections using a t cell or viral activator and anti-retroviral combination therapy
US7653260B2 (en) 2004-06-17 2010-01-26 Carl Zeis MicroImaging GmbH System and method of registering field of view
US8582924B2 (en) 2004-06-30 2013-11-12 Carl Zeiss Microimaging Gmbh Data structure of an image storage and retrieval system

Also Published As

Publication number Publication date
DK154093C (da) 1989-04-10
NO159622B (no) 1988-10-10
ATE14899T1 (de) 1985-08-15
NZ195944A (en) 1984-07-06
NO810035L (no) 1981-07-09
JPS56103116A (en) 1981-08-18
GR72412B (fi) 1983-11-03
NO159622C (no) 1989-01-18
IL61863A0 (en) 1981-02-27
DK5481A (da) 1981-07-09
MY8700059A (en) 1987-12-31
YU44321B (en) 1990-06-30
JPH0159872B2 (fi) 1989-12-20
PT72319B (en) 1982-07-23
ES8303917A1 (es) 1983-02-16
FI75600B (fi) 1988-03-31
IL61863A (en) 1984-07-31
AU6600281A (en) 1981-07-16
SG7186G (en) 1986-08-01
DE33579T1 (de) 1984-07-19
DE3171753D1 (en) 1985-09-19
FI75600C (fi) 1988-07-11
AU545185B2 (en) 1985-07-04
EP0033579A3 (en) 1981-12-30
PT72319A (en) 1981-02-01
ES498359A0 (es) 1982-12-16
JPS6410000B2 (fi) 1989-02-21
EP0033579A2 (en) 1981-08-12
HK24586A (en) 1986-04-11
JPS6413990A (en) 1989-01-18
IE810019L (en) 1981-07-08
US4364936A (en) 1982-12-21
EP0033579B1 (en) 1985-08-14
YU2881A (en) 1984-04-30
IE50802B1 (en) 1986-07-23
DK154093B (da) 1988-10-10
ZA8198B (en) 1982-08-25
CA1175368A (en) 1984-10-02

Similar Documents

Publication Publication Date Title
FI810027L (fi) Hybridcellinje foer framstaellning av en monoklonal antikropp mot en maensklig monosytantigen den saolunda framstaellda antikroppen samt foerfaranden i vilka antikroppen anvaends
FI800846A (fi) En hybridcell-linje foer framstaellning av en monoklonal antikropp mot maenskliga t-celler antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaendes
NO159888C (no) Monoklonalt antistoff.
FI810026L (fi) Hybridcellinje foer framstaellning av monoklonal antikropp mot maenskliga t-cellers antigener den saolunda framstaellda antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaends
FI803758L (fi) Hybridcellinje foer framstaellning av en komplement-fixerande monoklonal antikropp mot maenskliga supressor-t-celler den sao framstaellda antikroppen och metoder i vilka antikroppen anvaends
NO159887C (no) Monoklonalt antistoff.
FI803755L (fi) En hybridcell-linje foer framstaellning av en monoklonal antikropp mot en maensklig tymosytantigen antikroppen samt terapeutiska och diagnostiska metoder i vilka antikroppen anvaendes

Legal Events

Date Code Title Description
MA Patent expired

Owner name: ORTHO PHARMACEUTICAL CORPORATION